AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 12th, 2018 • Assembly Biosciences, Inc. • Pharmaceutical preparations • California
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), is entered into on October 10, 2018 (the “Effective Date“), by and between Assembly Biosciences, Inc., a Delaware corporation with principal executive offices at 11711 N. Meridian Street, Suite 310, Carmel, IN 46032 (the “Company”), and Uri A. Lopatin, MD (the “Executive”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • October 12th, 2018 • Assembly Biosciences, Inc. • Pharmaceutical preparations • California
WHEREAS, the Company and Executive have entered into the Employment Agreement dated as of December 17, 2015 and effective as of January 5, 2016 (the “Existing Agreement”).
STOCK APPRECIATION RIGHT award AGREEMENT for non-u.s. Grantees UNDER THE Assembly Biosciences, INc. 2018 STOCK INCENTIVE PLANStock Appreciation Right Award Agreement • October 12th, 2018 • Assembly Biosciences, Inc. • Pharmaceutical preparations • Delaware
Post-Termination Exercise Period Except as provided in Section 2, Vested SARs may be exercised for up to 90 days after termination of Continuous Service.
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • October 12th, 2018 • Assembly Biosciences, Inc. • Pharmaceutical preparations • Indiana
Amendment No. 1 to Employment AGREEMENT (this “Amendment No.1”), is entered into on October 10, 2018 (the “Amendment No. 1 Effective Date“), by and between Assembly Biosciences, Inc., a Delaware corporation with principal executive offices at 11711 N. Meridian Street, Suite 310, Carmel, IN 46032 (the “Company”), and Derek Small (the “Executive”).
